CBZ(CBZ)
CBZ
Q4 2026 EPS Estimate
$1.29
Nov 4, 2026 · Reports after close
Revenue Estimate
$727M
FY2026E EPS$4.10
FY2027E EPS$4.48
Analyst Sentiment
Wall St. Consensus
Hold3 analysts·Low coverage
58
Score
1 Buy (33%)2 Hold (67%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
133%
Hold
267%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$37.00
-32.7%
Consensus
$43.50
-20.9%
Bull
$55.00
-0.0%
12-Month Target Range3 analysts
$37.00$43.50$55.00
Current $55.01Consensus
Current Price
$55.01
Above Consensus
$11.51
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+4.38%
EPS+9.39%
FY2028
Rev+2.56%
EPS+11.98%
FY2029
Rev+1.82%
EPS+14.98%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $2.83B | $2.96B | $3.03B | $3.09B | $3.17B |
| Low | $2.82B | $2.94B | $3.01B | $3.06B | $3.14B |
| High | $2.84B | $2.98B | $3.06B | $3.11B | $3.19B |
| EBITDA Avg | $335M | $350M | $359M | $366M | $375M |
| Low | $334M | $348M | $356M | $362M | $371M |
| High | $337M | $352M | $362M | $368M | $378M |
| EBIT Avg | $260M | $272M | $278M | $284M | $291M |
| Low | $259M | $270M | $276M | $281M | $288M |
| High | $261M | $273M | $281M | $286M | $293M |
| Net Income Avg | $259M | $284M | $317M | $365M | $420M |
| Low | $257M | $276M | $313M | $360M | $414M |
| High | $262M | $292M | $320M | $368M | $424M |
| EPS Avg | $4.10 | $4.48 | $5.02 | $5.77 | $6.64 |
| Low | $4.06 | $4.37 | $4.95 | $5.69 | $6.55 |
| High | $4.15 | $4.62 | $5.07 | $5.83 | $6.71 |
| Analysts (Rev / EPS) | 4 / 4 | 4 / 4 | 2 / 1 | 1 / 1 | 1 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $727M | $569M | $885M | $728M | $758M | $594M | $914M | $747M |
| Low | $717M | $566M | $870M | $716M | $745M | $584M | $898M | $734M |
| High | $732M | $572M | $891M | $734M | $764M | $598M | $920M | $753M |
| EBITDA Avg | $86M | $67M | $105M | $86M | $90M | $70M | $108M | $88M |
| Low | $85M | $67M | $103M | $85M | $88M | $69M | $106M | $87M |
| High | $87M | $68M | $105M | $87M | $90M | $71M | $109M | $89M |
| EBIT Avg | $67M | $52M | $81M | $67M | $70M | $54M | $84M | $69M |
| Low | $66M | $52M | $80M | $66M | $68M | $54M | $82M | $67M |
| High | $67M | $52M | $82M | $67M | $70M | $55M | $84M | $69M |
| Net Income Avg | $76M | $-29M | $155M | $58M | $86M | $-29M | $176M | $63M |
| Low | $71M | $-30M | $152M | $57M | $84M | $-29M | $172M | $62M |
| High | $80M | $-28M | $157M | $59M | $87M | $-28M | $177M | $64M |
| EPS Avg | $1.28 | $-0.49 | $2.60 | $0.98 | $1.45 | $-0.49 | $2.94 | $1.06 |
| Low | $1.19 | $-0.50 | $2.55 | $0.95 | $1.41 | $-0.49 | $2.88 | $1.04 |
| High | $1.34 | $-0.46 | $2.63 | $0.99 | $1.46 | $-0.47 | $2.97 | $1.07 |
| Analysts (Rev / EPS) | 4 / 3 | 4 / 3 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 | 1 / 2 | 1 / 2 |